Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing the attention of investors with its promising potential upside. Headquartered in..
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising pipeline in the healthcare industry. With a market..
ResMed Inc. (RMD) stands as a formidable entity within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $40 billion, ResMed’s influence spans..
Royalty Pharma plc (NASDAQ: RPRX) is carving out a distinct niche in the healthcare sector as a prominent player in the biotechnology industry. Specializing in the acquisition of biopharmaceutical royalties..
RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $5.88 billion, RadNet is a major player..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is a formidable player in the biotechnology sector, focusing primarily on RNA-targeted medicines. With a market capitalization of $9.72 billion, Ionis stands at the forefront..
Alkermes plc (NASDAQ: ALKS) is capturing investor attention with its impressive potential upside of nearly 50%, positioning itself as a compelling contender in the healthcare sector. This Ireland-based biopharmaceutical company..
Stevanato Group S.p.A. (NYSE: STVN) has emerged as a noteworthy player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. Headquartered in Piombino Dese, Italy, Stevanato Group..
Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with a remarkable potential upside that has captured the attention of investors. With a market capitalization of $8.14..
Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology industry, is making waves in the healthcare sector with its innovative approach to drug development. Based in the United Kingdom..
Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, stands as a prominent player in the medical instruments and supplies industry. With a market capitalization of $53.61..
Medpace Holdings, Inc. (NASDAQ: MEDP) is a significant player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace provides a comprehensive suite of..
The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors. With a market..
Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, is known for its innovative solutions in the medical instruments and supplies industry. With a market capitalization of..
Danaher Corporation (NYSE: DHR), a titan in the healthcare diagnostics and research sector, commands the attention of investors with its robust market capitalization of $138.41 billion. This US-based company, known..
Fresenius Medical Care AG (NYSE: FMS), a powerhouse in the healthcare sector, stands at the forefront of providing dialysis and related services worldwide. With a market capitalization of $14.96 billion,..
The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $77.51 billion, Cigna is a..
Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a compelling investment opportunity. With a market capitalization of $4.79 billion, Glaukos..
DaVita Inc. (NYSE: DVA), a leader in the healthcare sector specializing in kidney dialysis services, offers a compelling investment opportunity with a potential upside of 17.93%. Headquartered in Denver, Colorado,..
Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is capturing investor attention with its robust 25.10% potential upside, as indicated by its average target price of $12.19...
